Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S2 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance
  1. Home
  2. Publications
  3. Table S2 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Table S2 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Authors:
  • CLChengxi Li
    Chengxi Li
  • YCYu-Hsuan Chang
    Yu-Hsuan Chang
  • MMMinori Maki
    Minori Maki
  • IOIkuko Omori
    Ikuko Omori
  • NSNaru Sato
    Naru Sato
  • SGSusumu Goyama
    Susumu Goyama
  • TKToshio Kitamura
    Toshio Kitamura
  • YEYutaka Enomoto
    Yutaka Enomoto

Open Access
Publisher website
Google Scholar
  • 2 October 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.34055551
Abstract
Culture conditions of drug-resistant cell lines
Keywords
  • CHEMOTHERAPY
  • COMBINATION CHEMOTHERAPY
  • DRUG RESISTANCE
  • REGULATION OF GENE EXPRESSION IN DRUG RESISTANCE
  • HEMATOLOGICAL CANCERS
  • LEUKEMIAS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.